Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An update from Otsuka Holdings Co ( (JP:4578) ) is now available.
Otsuka Holdings has revised its consolidated financial forecasts for FY2024, anticipating a significant increase in profits due to a temporary tax adjustment in the U.S. and strong performance in its pharmaceutical and nutraceutical businesses. Key products driving this growth include antipsychotic and anti-cancer agents, as well as health beverages like POCARI SWEAT and Nature Made, positioning Otsuka for continued success and exceeding previous earnings expectations.
More about Otsuka Holdings Co
Otsuka Holdings Co., Ltd. operates in the pharmaceutical and nutraceutical industries, focusing on products such as antipsychotic agents, anti-cancer drugs, and health beverages with a market presence in Asia and North America.
YTD Price Performance: -3.04%
Average Trading Volume: 1,314
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $28.07B
See more data about 4578 stock on TipRanks’ Stock Analysis page.
